Clinical trial

Studies of Insulin and Glucagon Action in the Liver

NCT07300982

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-10-01

PhasePHASE1 / PHASE2

Study timeline

Study start (estimated)2026-10-01Date precision: month

Registry last updated2026-08-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes (DM)unresolved

Interventions

GlucagonDRUG · verified · RxNorm: glucagon

Saline (placebo)DRUG

Sponsors & collaborators

Duke Universitylead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

DurhamNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07300982 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.